Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/26/2006
 
First Published:
7/1/2002
1.
Phase II Pilot Study of Etanidazole Derivative EF5 for the Measurement of Tumor Hypoxia in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic
Closed
18 and over
NCI
DUMC-0041-M1RB00622
NCI-2310, NCT00041028, 2310
Last Modified:
11/14/2006
 
First Published:
11/1/2002
2.
Phase II Pilot Diagnostic Study of EF5 Uptake and Concentration of Oxygen-Related Metabolites in Patients With Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic
Completed
18 and over
NCI
DUMC-3512-02-3
NCI-5929, NCT00049140, 5929
Last Modified:
10/23/2006
 
First Published:
11/24/2002
3.
Phase II Randomized Study of Hyperbaric Oxygen Treatments in Previously Treated Patients With Laryngeal or Adjacent Pharyngeal Malignancies Undergoing Laryngectomy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
18 and over
NCCAM, NCI
UPCC-17300
NCI-5909, UPCC-IRB-702641, 5909, NCT00026975
Last Modified:
7/19/2007
 
First Published:
3/24/2005
4.
Phase II Pilot Study of EF5 Binding for the Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic, Treatment
Completed
18 and over
NCI
UPCC-03804
7034, NCI-7034, NCT00107445
Last Modified:
5/27/2005
 
First Published:
5/1/1998
5.
Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Diagnostic, Treatment
Completed
18 and over
NCI
UPCC-7597
NCI-T97-0045, NCT00003282, T97-0045, UPCC-1663-0
Last Modified:
6/1/2002
 
First Published:
2/1/2000
6.
Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Breast, Head and Neck, Prostate, or Cervical Carcinoma or High Grade Soft Tissue Sarcomas (Summary Last Modified 06/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Diagnostic
Closed
18 and over
NCI
CAN-OCI-T98-0048
NCI-T98-0048, NCT00004261, T98-0048
Last Modified:
1/30/2007
 
First Published:
4/23/2005
7.
Phase I Study of Positron Emission Tomography Using Fluorine F 18 EF5 for the Detection of Tumor Hypoxia in Patients With Newly Diagnosed Brain Tumors Undergoing Surgery or Biopsy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Diagnostic, Treatment
Completed
18 and over
NCI
UPCC-01304
NCI-5999, 5999, NCT00110032
Last Modified:
10/15/2007
 
First Published:
1/25/2007
8.
Study of Etanidazole Derivative EF5 for Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Treatment
Completed
18 and over
NCI
UPCC-1301
UPCC-IRB-702859, NCI-4950, 4950, NCT00430079
Last Modified:
10/15/2007
 
First Published:
1/1/2002
9.
Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia and Vascularity in Patients With Intraperitoneal or Pleural Malignancies Treated With Photodynamic Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Completed
18 and over
NCI
UPCC-05901
NCI-4110, 4110, UPCC-IRB-702341, NCT00028782
Last Modified:
10/15/2007
10.
Study of EF5 for the Detection of Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma of the Trunk or Extremity or Squamous Cell Carcinoma of the Oral Cavity
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis
Completed
18 and over
NCI
UPCC-3300
UPCC-IRB-701019, NCI-3950, 3950
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute